Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Your safety is our priority, and treatments are provided with careful oversight
Analyst Commentary: Bernsteins Breen argued the $10B price rested on optimistic assumptions and that Pfizer must drive ~$11B revenue from Metseras drugs by 2040 ( [34] )
Durvalumab with olaparib and paclitaxel for high-risk HER2negative stage II/III breast cancer: results from the adaptively randomized I-SPY2 trial
Additionally, we explore natural compounds and extracts studied for their antioxidant properties, offering potential therapeutic avenues for managing free radical-induced damage
US$ 21.92
US$ 27.26
US$ 24.22
US$ 28.86
US$ 20.45
